| | | | |
Research
|
Occupational Toluene Exposure Induces Cytochrome P450 2E1 mRNA Expression in Peripheral Lymphocytes Ania Mendoza-Cantú,1 Fabiola Castorena-Torres,1 Mario
Bermúdez de León,2 Bulmaro Cisneros,2 Lizbeth
López-Carrillo,3 Aurora E. Rojas-García,1 Alberto
Aguilar-Salinas,4 Maurizio Manno,5 and Arnulfo Albores1 1Sección de Toxicología and 2Departamento
de Genética y Biología Molecular, Centro de Investigación
y de Estudios Avanzados, National Polytechnical Institute, Mexico City, Mexico; 3Centro
de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública,
Cuernavaca, Morelos, Mexico; 4Coordinación Nacional de Salud
en el Trabajo, Centro Médico Nacional Siglo XXI, Instituto Mexicano
del Seguro Social, Mexico City, Mexico; 5Dipartimento di Scienze
Mediche Preventive, Sezione di Tossicologia Occupazionale, Università degli
Studi di Napoli “Federico II,” Naples, Italy Abstract Print workers are exposed to organic solvents, of which the systemic toxicant toluene is a main component. Toluene induces expression of cytochrome P450 2E1 (CYP2E1) , an enzyme involved in its own metabolism and that of other protoxicants, including some procarcinogens. Therefore, we investigated the association between toluene exposure and the CYP2E1 response, as assessed by mRNA content in peripheral lymphocytes or the 6-hydroxychlorzoxazone (6OH-CHZ) /chlorzoxazone (CHZ) quotient (known as CHZ metabolic ratio) in plasma, and the role of genotype (5´-flanking region RsaI/PstI polymorphic sites) in 97 male print workers. The geometric mean (GM) of toluene concentration in the air was 52.80 ppm (10-760 ppm) ; 54% of the study participants were exposed to toluene concentrations that exceeded the maximum permissible exposure level (MPEL) . The GM of urinary hippuric acid at the end of a work shift (0.041 g/g creatinine) was elevated relative to that before the shift (0.027 g/g creatinine ; p < 0.05) . The GM of the CHZ metabolic ratio was 0.33 (0-9.3) , with 40% of the subjects having ratios below the GM. However, the average CYP2E1 mRNA level in peripheral lymphocytes was 1.07 (0.30-3.08) , and CYP2E1 mRNA levels within subjects correlated with the toluene exposure ratio (environmental toluene concentration:urinary hippuric acid concentration) (p = 0.014) . Genotype did not alter the association between the toluene exposure ratio and mRNA content. In summary, with further validation, CYP2E1 mRNA content in peripheral lymphocytes could be a sensitive and noninvasive biomarker for the continuous monitoring of toluene effects in exposed persons. Key words: chlorzoxazone, CYP2E1 mRNA induction, lymphocytes, occupational exposure, toluene. Environ Health Perspect 114:494-499 (2006) . doi:10.1289/ehp.8192 available via http://dx.doi.org/ [Online 13 October 2005]
Address correspondence to A. Albores, Sección de Toxicología, Cinvestav-IPN, Ave. IPN 2508, Col. Zacatenco, CP 07360, Mexico City, Mexico. Telephone: 52-55-5061-3308. Fax: 52-55-5061-3395. E-mail: aalbores@cinvestav.mx We thank L.M. Del Razo and L. Sarkissian for critical review and R.A. Reyes Mejía and M.L. López González for analytical work. This investigation was supported by CONACYT Mexico (project M0061-M9602) , which also provided a grant to A.M.-C. (95754) , and the Mexico-Italy Cooperation Program 2003-2005 (project 27) . The authors declare they have no competing financial interests. Received 11 April 2005 ; accepted 12 October 2005. |
|
|
|
|
|
[References Listed in PubMed]
Apostoli P, Brugnone F, Perbellini L,
Cocheo V, Bellomo ML, Silvestri R. 1982. Biomonitoring of
occupational toluene exposure. Int Arch Occup Environ Health
50: 153-168.
ATSDR. 2000. Toxicological Profile for Toluene.
Atlanta, GA:Agency for Toxic Substances and Disease
Registry.
Badger TM, Huang J, Ronis M, Lumpkin CK. 1993.
Induction of cytochrome P450 2E1 during chronic
ethanol exposure occurs via transcription of the
CYP2E1 gene when blood alcohol concentrations are
high. Biochem Biophys Res Commun 190: 780-785.
Bartels H, Bohmer M, Heierli C. 1972. Serum creatinine
determination without protein precipitation. Clin
Chem Acta 37:193-197.
Bebia Z, Buch SC, Wilson JW, Frye RF, Romkes
M, Cecchetti A, et al. 2004. Bioequivalence revisited:
influence of age and sex on CYP enzymes. Clin Pharmacol
76: 618-627.
Benowitz NL, Peng M, Jacob P III. 2003. Effects
of cigarette smoking and carbon monoxide on chlorzoxazone
and caffeine metabolism. Clin Pharmacol Ther 74:
468-474.
Bergmeyer HU, Horder M. 1980. International Federation
of Clinical Chemistry, Scientific Committee. Expert
panel on enzymes. IFCC document stage 2, draft
1; 1979-11-19 with a view to an IFCC recommendation.
IFCC methods for the measurement of catalytic concentration
of enzymes. Part 3. IFCC method for alanine aminotransferase.
J Clin Chem Clin Biochem 18:521-534.
Boyum A. 1968. Separation of leucocytes from
blood and bone marrow. Introduction. Scand J Clin
Lab Invest Suppl 97:7.
Brown K. 1995. Physical Status: The Use and Interpretation
of Anthropometry. WHO Technical Report Series 854.
Geneva:World Health Organization.
Byrne A, Kirby B, Sibin T, Ensminger S. 1991.
Psychiatric and neurological effects of chronic
solvent abuse. Can J Psychiatry 36:735-738.
Campo P, Lataye R, Cossec B, Villete V, Roure
M, Barthelemy C. 1998. Combined effects of simultaneous
exposure to toluene and ethanol on auditory function
in rats. Neurotoxicol Teratol 20:321-332.
Cocheo V. 1983. Sampling of solvents on active
charcoal: chemical and thermal recovery. G Ital
Med Lav 5:153-158.
De Bruin A. 1980. Biochemical Toxicology of Environmental
Agents. 2nd ed. Amsterdam:Elsevier, 426-434.
Ernstgård L, Gullstrand E, Johanson G,
Löf A. 1999. Toxicokinetic interactions between
orally ingested chlorzoxazone and inhaled acetone
or toluene in male volunteers. Toxicol Sci 48:189-196.
Frye RF, Branch RA. 2002. Effect of chronic disulfiram
administration on the activities of CYP1A2, CYP2C19,
CYP2D6, CYP2E1, and N-acetyltransferase in healthy
human subjects. Br J Clin Pharmacol 53:155-62.
Gonzalez-Jasso E, Lopez T, Lucas D, Berthou F,
Manno M, Ortega A, et al. 2003. CYP2E1 regulation
by benzene and other small organic chemicals in
rat liver and peripheral lymphocytes. Toxicol Lett
144:55-67.
Guengerich FP, Shimada T. 1991. Oxidation of
toxic and carcinogenic chemicals by human cytochrome
P-450 enzymes. Chem Res Toxicol 4:391-407.
Hayashi SI, Watanabe J, Kawajiri K. 1991. Genetic
polymorphism in the 5’-flanking region change
the transcriptional regulation of the human cytochrome
P450IIE1 gene. J Biochem (Tokyo) 110:559-565.
Kawamoto T, Koga M, Oyama T, Kodama Y. 1996.
Habitual and genetic factors that affect urinary
background levels of biomarkers for organic solvent
exposure. Arch Environ Contam Toxicol 30:114-120.
Klug WS, Cummings MR. 2000. Concepts of Genetics.
6th ed. Upper Saddle River, NJ:Prentice Hall.
Lieber CS. 1997. Cytochrome P-4502E1: its physiological
and pathological role. Physiol Rev 77: 517-544.
Lieber CS. 2004. The discovery of the microsomal
ethanol oxidizing system and its physiologic and
pathologic role. Drug Metab Rev 36:511-529.
Lucas D, Berthou F, Girre C, Poitrenaud F, Menez
JF. 1993. High-performance liquid chromatographic
determination of chlorzoxazone and 6-hydroxychlorzoxazone
in serum: a tool for indirect evaluation of cytochrome
P4502E1 activity in humans. J Chromatogr 622:79-86.
Lucas D, Ferrara R, Gonzales E, Albores A, Manno
M, Berthou F. 2001. Cytochrome CYP2E1 phenotyping
and genotyping in the evaluation of health risks
from exposure to polluted environments. Toxicol
Lett 124:71-81.
Lucas D, Ferrara R, Gonzalez E, Bodenez P, Albores
A, Manno M, et al. 1999. Chlorzoxazone, a selective
probe for phenotyping CYP2E1 in humans. Pharmacogenetics
9: 377-388.
Madrigal-Bujaidar E, Piña A, Hernández
I. 1996. Exposición ocupacional a disolventes
orgánicos. Rev Mex Patol Clin 43: 15-20.
Mendoza-Cantú A, Castorena-Torres F, Bermudez
M, Martínez-Hernández R, Ortega A,
Salinas JE, et al. 2003. Genotype and allele frequencies
of polymorphic cytochromes P450 CYP1A2 and CYP2E1
in Mexicans. Cell Biochem Funct 22:29-34.
Mercado-Calderón F. 1997. Contaminantes
orgánicos volátiles. In: Introducción
a la Toxicología Ambiental (Albert L, ed).
Mexico City:Centro Panamericano de Ecología
Humana y Salud, División de Salud y Ambiente,
Organización Panamericana de la Salud, y
Organización Mundial de la Salud, 299-313.
Mutti A. 1999. Biological monitoring in occupational
and environmental toxicology. Toxicol Lett 108:
77-89.
Nakajima T, Wang RS. 1994. Induction of cytochrome
P450 by toluene. Int J Biochem 26:1333-1340.
NIOSH (National Institute of Occupational Safety
and Health). 1994. Hippuric and Methyl Hippuric
Acids in Urine. In: Manual of Analytical Methods.
4th ed. Available: http://www.cdc.gov/niosh/nmam/pdfs/8301.pdf [accessed 27 January 2006].
NOM-047-SSA1-1993. 1996. Norma Oficial Mexicana
que Establece los Límites Biológicos
Máximos Permisibles de Disolventes Orgánicos
en el Personal Ocupacionalmente Expuestos (Mexican
Official Regulation). Diario Oficial de la Federación,
19 September and 23 September. DXVI 13:32-37
and 15:101-106.
NOM-010-STPS-1999. 2000. Norma Oficial Mexicana
que Establece las Condiciones de Seguridad e Higiene
en los Centros de Trabajo donde se Manejen, Transporten,
Procesen o Almacenen Sustancias Químicas
Capaces de Generar Contaminación en el Medio
Ambiente Laboral (Mexican Official Regulation).
Diario Oficial de la Federación, 13 March.
DLVIII 9, 2nd Section:1-128, 3rd Section:1-128
and 4th Section:1-128.
Park KS, Sohn DH, Veech RL, Song BJ. 1993. Translational
activation of ethanol-inducible cytochrome P450
(CYP2E1) by isoniazid. Eur J Pharmacol 248:7-14.
Plee-Gautier E, Foresto F, Ferrara R, Bodenez
P, Simon B, Manno M, et al. 2001. Genetic repeat
polymorphism in the regulating region of CYP2E1:
frequency and relationship with enzymatic activity
in alcoholics. Alcohol Clin Exp Res 25:800-804.
Powell H, Kitteringham NR, Pirmohamed M, Smith,
DA, Park BK. 1998. Expression of cytochrome P4502E1
in human liver: assessment by mRNA, genotype and
phenotype. Pharmacogenetics 8:411-421.
Raucy JL, Schultz ED, Wester MR, Arora S, Johnston
DE, Omdahl JL, et al. 1997. Human lymphocytes cytochrome
P450 2E1, a putative marker for alcohol-mediated
changes in hepatic chlorzoxazone activity. Drug
Metabol Disp 25: 1429-1435.
Roberts BJ, Song BJ, Soh Y, Park SS, Shoaf SE.
1995. Ethanol induces CYP2E1 by protein stabilization.
Role of ubiquitin conjugation in the rapid degradation
of CYP2E1. J Biol Chem 270:29632-29635.
Shayiq RM, Roberts DW, Rothstein K, Snawder JE,
Benson W, Ma X, et al. 1999. Repeat exposure to
incremental doses of acetaminophen provides protection
against acetaminophen-induced lethality in mice:
an explanation for high acetaminophen dosage in
humans without hepatic injury. Hepatology 29:451-463.
Simi A, Ingelman-Sundberg M. 1999. Post-translational
inhibition of cytochrome P-450 2E1 expression by
chlomethiazole in Fao hepatoma cells. J Pharmacol
Exp Ther 289:847-852.
Sumida A, Kinoshita K, Fukuda T, Matsuda H, Yamamoto
I, Inaba T, et al. 1999. Relationship between mRNA
levels quantified by reverse transcription-competitive
PCR and metabolic activity of CYP3A4 and CYP2E1
in human liver. Biochem Biophys Res Commun 262:499-503.
Tanaka E, Kurata N, Yasuhara H. 2003. How useful
is the “cocktail approach” for evaluating
human hepatic drug metabolizing capacity using
cytochrome P450 phenotyping probes in vivo? J Clin
Pharm Ther 28:157-165.
Tardif R, Lapare S, Krishnan K, Brodeur J. 1993.
Physiologically based modeling of the toxicokinetic
interaction between toluene and m-xylene in the
rat. Toxicol Appl Pharmacol 120:266-273.
Uaki H, Kawai T, Mizunuma K, Moon CS, Zhang ZW,
Inui S, et al. 1995. Dose-dependent suppression
of toluene metabolism by isopropyl alcohol and
methyl ethyl ketone after experimental exposure
of rats. Toxicol Lett 81: 229-234.
Wallen M. 1986. Toxicokinetics of toluene in
occupationally exposed volunteers. Scand J Work
Environ Health 12:588-593.
Wormhoudt LW, Commandeur JN, Vermeulen NP. 1999.
Genetic polymorphisms of human N-acetyltransferase,
cytochrome P450, glutathione-S-transferase, and
epoxide hydrolase enzymes: relevance to xenobiotic
metabolism and toxicity. Crit Rev Toxicol 29:59-124.
Last Updated: March 7, 2006 |
|
|
|
| |